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ABSTRACT 
The status of human papillomavirus (HPV) infection in urothelial inverted papilloma was 
examined in the present study. Formalin-fixed and paraffin-embedded tissues from eight cases 
of inverted papilloma of the bladder were studied. The presence of HPV-DNA was examined by 
modified GP5/6+PCR using archival tissue sections by microdissection. HPV genotype was 
determined with a Hybri-Max HPV genotyping kit. Immunohistochemical analysis for 
p16-INK4a, mcm7, HPV-E4, and L1, and in situ hybridization (ISH) for the HPV genome were 
performed. HPV was detected in 7 of 8 cases (87.5%) of inverted papilloma. Three cases were 
diagnosed as inverted papilloma with atypia, while the remaining 5 were typical cases. HPV-18 
was detected in two cases, including one inverted papilloma with atypia, and HPV-16 was 
detected in four cases, including one inverted papilloma with atypia. Multiple HPV type 
infection was detected in one typical case and one atypical case. High-risk HPV was present in 
all HPV-positive cases. Cellular proteins, p16-INK4a and mcm7, which are surrogate markers 
for HPV-E7 expression, were detected in all HPV-positive cases, and their levels were higher in 
inverted papilloma with atypia than in typical cases. In contrast, HPV-E4 and L1, which are 
markers for HPV propagation, were observed in some parts of the typical inverted papilloma 
tissue. High-risk HPV infection may be one of the causes of urothelial inverted papilloma, and 
inverted papilloma with atypia may have malignant potential. 
Key Words: human papillomavirus, inverted papilloma, in situ hybridization, p16, mcm7 
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INTRODUCTION 
Certain types of human papillomavirus (HPV), which are transmitted through sexual 
contact, are thought to be causative agents of cervical cancer and some other cancers. HPV is 
highly prevalent in sexually active young men and women. However, many studies have 
suggested that men only act as a reservoir for HPV transmission, as urothelial malignancies are 
considered to be induced rarely by HPV. However, HPV has been detected in some cases of 
urothelial carcinoma in the bladder [Barghi et al., 2005; Moonen et al., 2007]. Bladder cancer 
generally develops in men over 60 years old in contrast to cervical cancer in younger women, 
suggesting that HPV is unlikely to induce bladder cancer with a high incidence rate. Indeed, 
HPV-DNA detection is much less frequent in bladder cancer than in cervical cancer, and 
various rates of positivity for HPV-DNA in bladder cancer have been reported [Barghi et al., 
2005; Moonen et al., 2007; Tenti et al., 1996; Kamel et al., 1995]. Thus, the etiological role of 
HPV in bladder cancer is still controversial. 
Inverted papilloma is a rare benign urothelial tumor that develops predominantly in the 
bladder, and accounts for less than 1% of all urothelial neoplasms [Sung et al., 2006b]. This 
type of tumor is characterized pathologically by inverted growth of transitional epithelia with no 
atypia. Generally, inverted papilloma occurs more frequently in men than in women, and the 
most common target age is 30 to 60 years old, which is younger than bladder cancer [Sung et al., 
2006b]. Although the etiological factors associated with inverted papilloma have not been 
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established, HPV-DNA has been detected in some cases of inverted papilloma [Chan et al., 
1997]. A recent study reported a high prevalence (35%) of HPV infection in the urinary tracts 
(urethra and urine) of 142 men with urethritis [Shigehara et al., 2010], and morphological 
abnormal cells suggestive of high-risk HPV infection were identified on Papanicolaou test of 
scraped cells from the lower segment of the urethra, suggesting that persistent HPV infection in 
the urinary tract may be a cause of bladder neoplasm. 
Here, in the present study, the presence of HPV-DNA in the tissue of inverted 
papilloma of the bladder was examined using a microdissection procedure, and the status of 
HPV infection in the tissue was also investigated using an immunohistochemical (IHC) method 




MATERIALS AND METHODS 
 
Patients 
Eight cases of inverted papilloma of the bladder treated at Kanazawa University 
Hospital between 2000 and 2009 were investigated in this study. Histopathological diagnosis of 
inverted papilloma was made based on 2004 World Health Organization classification of 
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noninvasive urothelial tumors [Lopez-Beltran et al., 2004]. Written informed consent for usage 
of these samples had already been obtained from all patients before surgical resection, in 
accordance with the protocol approved by the Ethics Committee of Kanazawa University 
Graduate School of Medicine. 
 
Samples 
The inverted papilloma tissues were fixed immediately in 20% formalin, embedded in 
paraffin, and stored at room temperature. The cases were classified pathologically into two 
groups: the first was composed of normal urothelial cells (classical or typical inverted 
papilloma), showing thin anastomosing trabeculae of urothelium that grow downward into the 
stroma and absence of a papillary component; and the second was inverted papilloma with 
atypia (atypical inverted papilloma), which had foci of atypia in a background of classic 
inverted papilloma, as reported previously [Broussard et al., 2004]. Seven paraffin-embedded 
normal mucosal samples, which were obtained by random bladder biopsy from another seven 
patients with inflammatory bladder disorder, were used as negative controls. 
 
HPV-DNA analysis and typing 
DNA was extracted from paraffin-embedded inverted papilloma tissue and controls by 
microdissection using the Pinpoint Slide DNA Isolation System™ (Zymo Research, Orange, 
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CA). The extracted DNA was stored at –30°C until use. 
DNA quality was confirmed by amplifying the β-globin gene as an internal control by 
PCR. HPV-DNA was amplified using a modified GP5+/GP6+ PCR method as reported 
previously [Yamada et al., 2008]. HPV was defined as positive when a band of about 140 bp 
was observed after electrophoresis of 8 μL of PCR product on 2.0% agarose gels and staining 
with ethidium bromide. 
 HPV genotyping was performed using an HPV GenoArray Test Kit (HybriBio Ltd., 
Chaozhou, China). This assay can determine 21 HPV types, including 14 high-risk HPV types 
(16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), 5 low-risk HPV types (6, 11, 42, 43, 
and 44), and two unknown-risk types (53 and CP8304), by the flow-through hybridization 
technique using HPV-DNA amplified by PCR [Shigehara et al., 2010]. 
 
In situ hybridization for HPV-DNA 
ISH was performed to detect HPV-DNA in tumor tissue using an HPV-detection kit 
according to the manufacturer’s instructions (Dako GenoPoint System K0620; Dako, 
Carpinteria, CA). A wide-spectrum probe (Y1404; Dako) for 13 high-risk HPV-DNA (HPV 
types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68), and low-risk HPV-DNA (HPV types 
6, 11) probe (Y1411; Dako), and HPV types 16, 18 probe (Y1412; Dako) were hybridized with 
denatured DNA on tissue samples. HPV-DNA signals were visualized as brownish staining. 
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Hematoxylin was used to counterstain the cell nuclei in all specimens.  
 
Immunohistochemistry for HPV-related proteins 
The procedure for IHC staining was performed using a Dako ChemMate ENVISION 
Kit/HRP(DAB)-universal kit (K5007) according to the manufacturer’s protocol (Dako). Tissue 
specimens were stained with mouse monoclonal antibodies against p16-INK4a 
(Immuno-Biological Laboratories Co., Ltd., Gunma, Japan) and against mini chromosome 
maintenance protein-7 (mcm-7) (Abnova, Taipei, Taiwan), and against HPV-L1 protein 
(Viroactiv; Virofem Diagnostica GmbH, Mainz, Germany). HPV-E4 staining was performed 
using a type-specific rabbit polyclonal antibody against E4 proteins of HPV-6, -11, -16, -18, and 
-33 according to the protocol described previously [Doorbar, 2006]. 
Antigen retrieval was performed by heating tissue sections at 95°C in Retrieval Solution, 
pH 9 (S2367; Dako) for 40 min. After blocking endogenous peroxidase activity using 3% 
hydrogen peroxide for 5 min, the sections were incubated with the primary antibodies at room 
temperature for 30 min, followed by incubation for 30 min with peroxidase-labeled secondary 
antibody (a mixture of rabbit and mouse antibodies) combined with dextran-polymers. 
Brownish staining for target proteins on tissue slides was developed using DAB, and 
counterstained with hematoxylin. The expression of each protein was scored according to the 
following scale: Distribution of signals were defined as 0 (<5% of the cells were positive), 1+ 
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(some: 5%–30% of the cells were positive), 2+ (many: 30%–50% of the cells were positive) and 
3+ (extensive: ≧50% of the cells were stained), The intensity of the signals was as 0 (not 
stained), 1+ (moderately stained) and 2+ (strongly stained). We calculated the score as 
multiplying the distribution score and the intensity score, and the expression levels of p16 and 





Detection of HPV genomes in inverted papilloma tissue 
Eight cases of inverted papilloma were investigated, and all results are summarized in 
Table I. Five cases (case 3, 4, 5, 7, 8) were diagnosed as typical inverted papilloma 
characterized by anastomosing cords and thin nests of normal urothelium growing down from 
the surface of the epithelium, and often formed glandular or gland-like structures (Fig. 1A, B). 
In contrast, three cases (case 1, 2, 6) were composed of various degrees of abnormal cell nests 
containing cells of increased chromatin, irregular nuclear contours, and increased 
nuclear/cytoplasmic ratios, with a loss of cell polarity (Figs. 1C, D). 
HPV-DNA was detected in seven cases (87.5%). HPV-16 was identified in four cases, 
including three typical and one atypical inverted papilloma. HPV-18 was detected in one typical 
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and one atypical inverted papilloma. Multiple HPV type infection was observed in two cases 
(one typical and one atypical inverted papilloma). The former was positive for HPV types 6, 16, 
and 33, and the latter was positive for HPV types 33, 58, and 68. High-risk HPV types were 
identified in all of HPV-positive cases. 
ISH analysis revealed the presence of high-risk HPV-DNA in the nuclei of most of the 
tumor cells in all HPV-positive cases (Fig. 2A). Different signal patterns were observed 
between typical and atypical inverted papilloma. Punctate signals, which may represent 
HPV-DNA integration, were predominant in atypical inverted papillomas (Fig. 2B, Table I), 
whereas diffuse and intense signals, which are due to plasmid state of HPV-DNA, were seen in 
typical inverted papilloma (Figs. 2C, Table I). HPV-DNA signals for HPV-16 and HPV-18 
were detected in cases 1, 3, 4, 5, 6, and 7. On the other hand, no HPV-DNA signals were 
detected in one HPV-negative case. HPV-6 and HPV-11 signals were seen only in case 3 
infected with HPV-6 (Fig. 2D, Table I). The HPV type determined with ISH was consistent 
with that indicated by the HPV genotyping test.  
Both PCR method and ISH analysis demonstrated that HPV-DNA was not detected in 
any control bladder specimens. 
 
Expression of cellular proteins p16 and mcm7, which are surrogate markers of high-risk 
HPV-E7 protein, in inverted papilloma 
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Cellular protein p16 is an inhibitor of cyclin-dependent kinase that stops the cell cycle. 
The expression can be enhanced by high-risk HPV-E7 protein, and the cell cycle inhibitory 
function of p16 is overridden in E7-expressing cells [Shai et al., 2007; Klaes et al., 2001]. 
Expression of mcm7 is also induced by E7 and contributes to cellular DNA replication [Brake et 
al., 2003]. These cellular proteins are therefore regarded as surrogate markers for the expression 
of E7 protein of high-risk HPV type in uterine cervical intraepithelial neoplasia (CIN) and 
cervical cancer. Both p16 and mcm7 were expressed in all HPV-positive cells in both typical 
and atypical inverted papilloma (Figs. 3A, B). The p16 and mcm7 signals were observed 
predominantly in the nucleus, and mcm7 was expressed faintly in the cytoplasm in some cells. 
The p16-positive inverted papilloma cells were observed more frequently than those positive for 
mcm7. Neither p16 nor mcm7 signal was observed in one case, which was negative for 
HPV-DNA, or in seven control specimens (Figs. 3C, D). 
The mean expression levels of these proteins were compared using a scoring system 
that recorded the distribution of the signals. Significant higher scores for mcm7 and marginally 
higher scores for p16 were observed in atypical than in typical inverted papilloma (Fig. 4). The 
levels of p16 or mcm7 expression represent proliferative activity induced by HPV infection, 
suggesting that atypical inverted papilloma may be more aggressive than typical cases. 
 
HPV infection status in inverted papilloma 
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There are two types of HPV infection, i.e., reproductive and abortive infection. The 
HPV-E4 protein is able to recognize the keratin network in host cells and stop cell division, 
which may facilitate the release HPV particles [Doorbar, 2006]. This protein is expressed 
abundantly during reproductive infection. HPV-E4 protein for each HPV type, such as HPV-6, 
-16, -18, and -33, was detected in all HPV-positive inverted papillomas (Table I, Figs. 5A, B, C), 
while no signals were seen for HPV-11-E4 protein (Table I, Fig. 5D). The E4 antibody was 
HPV type specific. HPV-E4 was expressed more strongly in the cytoplasm of typical inverted 
papilloma (Fig. 5C) than in atypical inverted papilloma (Fig. 5A). Curiously, nuclear staining 
was observed occasionally in some cases (Fig. 5B). HPV-E4 protein was not expressed in one 
HPV-negative inverted papilloma or in any controls. 
HPV-L1 protein is the major capsid protein that assembles to form the viral shell. L1 
protein was expressed widely only in case 4 (Fig. 6A), while a low level of expression was seen 
in limited parts of the inverted papilloma tissue of cases 1, 2, 3, and 6. The expression was 
limited to the apical sites of glandular structures and superficial layers of transitional cell 
epithelium in inverted papilloma (Figs. 6B, C). L1 protein expression was not observed in one 
HPV-18-positive case (case 5) and one HPV-16-positive case (case 7), although these were 
typical inverted papilloma cases. Furthermore, this protein was not detected in atypical sites of 






Potts et al. [1963] first reported a benign bladder tumor designated as inverted 
papilloma in 1963. Traditionally, inverted papilloma has been regarded as a benign neoplasm or 
a hyperplastic reactive lesion. However, cases with recurrence or those with synchronous or 
metachronous urothelial carcinoma have generated uncertainly with regard to its malignant 
potential. A systematic review of 322 cases of inverted papilloma in the bladder indicated that 
the recurrence rates was 4% and the incidences of associated synchronous urothelial carcinoma 
and development of subsequent urothelial carcinoma were 6% and 3%, respectively [Cheng et 
al., 2005]. Overaccumulation of p53, overexpression of HER-2/neu, and increased proliferation 
index have been identified in some inverted papillomas, suggesting that it may be susceptible to 
malignant transformation [Urakami et al., 1996; Cheon et al., 1995]. However, the association 
of inverted papilloma with such molecular events is less frequent than in bladder urothelial 
carcinoma [Sung et al., 2006a]. Some studies have doubted the malignant potential of inverted 
papilloma, as its recurrence is very rare and inverted papilloma with atypia does not show high 
proliferation activity [Sung et al. 2006a; Broussard et al., 2004]. 
The etiology of inverted papilloma has not been determined. One study suggested an 
association between HPV infection and inverted papilloma of the bladder [Chan et al., 1997]. In 
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this previous study, in which the presence of the HPV genome was examined by HPV 
type-specific PCR for HPV types 6, 11, 16, 18, 31, and 33, HPV was detected in 60% (6/10) of 
cases of inverted papilloma. HPV-16 and HPV-18 were detected in 1 and 6 cases, respectively. 
The results of the present study indicated a strong association between high-risk HPV infection 
and inverted papilloma, as high-risk HPV-DNA was identified in seven (87.5%) of eight cases 
of inverted papilloma. Furthermore, the localization of HPV-DNA was confirmed by ISH 
analysis using specific probes for HPV-16, -18, and high-risk HPV types. HPV-16 was the most 
common type. Low-risk HPV i.e., HPV-6 was found in one case of inverted papilloma, but this 
case showed co-infection with two high-risk HPV types. These findings suggested that high-risk 
HPV is likely to be one of the causes for the development of inverted papilloma. A recent study 
indicated a high prevalence rate (35%) of high-risk HPV infection in the lower urinary tract 
(urethra and urine) in 142 male patients with urethritis, suggesting that incidental HPV infection 
occurs not only in the external genitalia but also in the lower urinary tract [Shigehara et al., 
2010]. It is not surprising that HPV could infect urothelium in the urinary bladder and consistent 
HPV infection may result in the development of urothelial neoplasm. 
Pathologically, two different entities were observed among the present cases of 
inverted papilloma. Some cases had foci of atypical urothelium composed of atypical cells with 
nuclear enlargement, increased chromatin, and thickening of the nuclear membrane, in a 
background of the classic inverted papilloma. Such cases were reported as inverted papilloma 
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with atypia [Broussard et al., 2004]. On the other hand, typical inverted papilloma was 
composed of anastomosing cords and thin nests of normal urothelium growing down from the 
surface epithelium, and sometimes accompanied with gland-like or glandular structures. In the 
present ISH analysis of HPV-DNA, diffuse (cases 3, 4, 7), punctate (cases 1, 2, 6), and mixed 
diffuse and punctate staining patterns (cases 5) were observed in the nuclei of inverted 
papilloma cells. It has been reported that the diffuse patterns represent the episomal state of the 
HPV genome in host cells, while punctate patterns indicate integration of the HPV genome into 
the host cells [De Marchi Triglia et al., 2009]. Integration is observed frequently in high-grade 
CIN and cervical cancer [De Marchi Triglia et al., 2009; Kalof et al., 2005], while the episomal 
state is seen in papilloma or in lower grade CIN [Cooper et al., 1991]. Interestingly, punctate 
signals (integration) were observed predominantly in atypical inverted papilloma, while diffuse 
signals (episomal) were seen in typical cases. 
The loss of p16 expression is often a critical event in the progression of tumors in 
many organs, including bladder cancer [Rocco et al., 2001]. In fact, some studies have indicated 
that p16 protein is downregulated in 19% to 60% of bladder cancers [Krüger et al., 2005; Yang 
et al., 2002; Niehans et al., 1999]. In contrast, it is well known that upregulation of p16 in the 
presence of HPV-E7 protein plays an important role in the process of carcinogenesis in cervical 
cancer [Shai et al., 2007; Klaes et al., 2001] and head and neck cancer [Hafkamp et al., 2003]. 
The mcm7 gene is also responsive to E2F, and is used as another surrogate marker expressed in 
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high-grade CIN and cervical cancer [Brake et al., 2003]. Therefore, we also investigated the 
expression of p16 and mcm7 proteins, which are surrogate markers of E7 protein. Higher levels 
expression of p16 and mcm7 indicate higher activity of cell division with high-level E7 protein 
expression. In the present study, p16 and mcm7 were expressed in all HPV-positive cells in both 
typical and atypical inverted papilloma, supporting the suggestion that HPV infection may be 
associated with the development of inverted papilloma of the bladder. Furthermore, p16 and 
mcm7 were expressed at higher levels in atypical than in typical inverted papilloma. These 
observations suggest that cell growth is more aggressive for atypical inverted papilloma. The 
findings of HPV-DNA integration and high-level expression of p16 and mcm7 proteins in 
atypical inverted papilloma suggested its potential for malignant conversion. The present 
findings suggest that high-risk HPV may be a causative agent of urothelial inverted papilloma, 
and atypical inverted papilloma may be a precursor of urothelial cancer. On the other hand, 
Broussard et al. excluded the potential of atypical inverted papilloma for malignant progression 
in experiments regarding Ki-67 and cytokeratin-20 expression in atypical inverted papilloma 
tissue [Broussard et al., 2004]. It is not surprising that expression levels of these cell 
proliferation markers are reduced in atypical inverted papilloma in comparison with carcinoma, 
as atypical inverted papilloma is thought only to be a precursor lesion for cancer.  
The main limitation of this study was the small number of specimens. Therefore, it 
will be important to confirm our hypothesis by further studies with larger numbers of specimens. 
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Further studies are also needed to determine whether expression of p16 and mcm7 coincides 
with HPV infection in randomized samples of bladder cancer to evaluate the possible etiological 
role of HPV in urothelial carcinoma. 
If HPV is one of the causative factors of inverted papilloma, this would raise the 
question of whether inverted papilloma is a source of HPV propagation or of abortive infection. 
In women, HPV infection is thought be reproductive in condyloma acuminate and CIN 1. 
However, it changes to an abortive infection in high-grade CIN and cervical cancer after many 
years of persistent infection. We also investigated the expression of HPV-E4 and L1 proteins 
that are concordant with cell cycle arrest and HPV propagation [Doorbar, 2006]. E4 protein 
expression was observed in all cases of HPV-positive inverted papilloma. Although E4 
expression is often observed in the cytoplasm of differentiating epithelial cells (Figure 5A, C), 
in some situations the expression was apparent in the nucleus of atypical inverted papilloma 
(Figure 5B). This may represent a different form of the protein, and it is interesting that 
N-terminal cleavage of HPV-16 E4, which removes its keratin binding motif, can lead to 
nuclear accumulation of E4 in experimental systems [Roberts et al., 1997; Wang et al., 2004]. 
We do not know the exact reason or mechanism for such aberrant expression patterns for E4 in 
atypical inverted papilloma. On the other hand, L1 protein expression was observed in five 
cases of inverted papilloma, although it was restricted to typical sites of glandular structures and 
superficial layers of transitional cells. The signals were not detected in two HPV-positive cases 
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that were typical inverted papilloma. These findings suggested that HPV propagation may occur 
in limited parts of the inverted papilloma tissue, but its extent may be limited. 
In conclusion, high-risk HPV may be one of the etiological factors for inverted 
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FIGURE LEGENDS 
Fig. 1. Histological findings of inverted papilloma stained with hematoxylin & eosin (HE). (A) 
Gland-like structure in typical inverted papilloma of case 3 (HE staining, magnification ×100) 
(B) Typical inverted papilloma of case 3, (HE staining, magnification ×400) (C) Inverted 
papilloma with atypia of case 1 (HE staining, magnification ×100). (D) Inverted papilloma with 
atypia of case 2 (HE staining, magnification ×400). 
 
Fig. 2. Localization and signal patterns of HPV-DNA in the inverted papilloma (inverted 
papilloma) by in situ hybridization analysis. (A) High-risk HPV-DNA signals in typical inverted 
papilloma of case 3 (magnification ×100) (B) Punctate signals of high-risk HPV-DNA in 
inverted papilloma with atypia of case 2 (magnification ×400). (C) Diffuse and intense signals 
of HPV-16/18-DNA in typical inverted papilloma of case 6 (magnification ×400). (D) No 
signals of HPV type 6/11-DNA in inverted papilloma of case 5 (magnification ×40). 
 
Fig. 3. Expression patterns of p16 and mcm7 proteins in the inverted papilloma (inverted 
papilloma) (magnification ×400). (A) The p16 signals in the nuclei of inverted papilloma cells 
of case 1. (B) The mcm7 signals in the nucleus of inverted papilloma cells of case 1. (C) No 
signals of mcm7 in control transitional cells. (D) No signals of p16 in control transitional cells. 
 
Fig. 4. Comparison of expression levels of p16 and mcm7 proteins in inverted papilloma with 
atypia and typical inverted papilloma (in seven HPV-positive cases) (Mann-Whitney U-test; P < 
0.05). 
 
Fig. 5. Expression patterns of HPV-E4 protein in inverted papilloma (inverted papilloma) 
(magnification ×400). (A) Abundant expression of HPV-18-E4 in the cytoplasm of inverted 
papilloma with atypia of case 1. (B) HPV-16-E4 expression in the nuclei of inverted papilloma 
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of case 3. (C) Expression of HPV-6-E4 protein in the cytoplasm of apical parts of gland-like 
structures in inverted papilloma of case 3. (D) No signals for HPV-11-E4 in inverted papilloma 
of case 1 (negative control). 
 
Fig. 6 Expression patterns of high-risk HPV-L1 protein in the inverted papilloma (inverted 
papilloma) (magnification ×400). (A) Abundant cytoplasmic expression of L1 in inverted 
papilloma of case 1. (B) L1 expression in the apical parts of gland-like structures of inverted 
papilloma of cases 2. (C) L1 expression in the superficial layers of transitional cell epithelium 
within inverted papilloma of case 4. (D) This protein was not expressed in atypical parts of 
inverted papilloma with atypia (case 1). 
 
case 1 case 2 case 3 case 4 case 5 case 6 case7 cases8
Age 36 58 35 49 78 37 66 53
Sex Male Male Female Male Male Male Male Male
Pathological finding atypical atypical typical typical typical atypical typical typical
Βglobin + + + + + + + +
HPV type 18 33,58,68 6,16,33 16 18 16 16 negative
In situ hybridization
2+ 2+ 1+ 1+ 1+ 1+ 2+







2+ +/- 2+ 2+ 2+ 2+ 
(punctate) (diffuse) (diffuse) (diffuse/punctate) (punctate) (diffuse)
Immunohistochemistory
(area/intensity/location)
  p16 3+/3+/N 3+/2+/N 2+/2+/N 2+/3+/N 2+/2+/N 3+/2+/N 2+/1+/NC -/-/-
 mcm7 2+/3+/NC 2+/2+/NC1+/2+/NC2+/2+/NC 1+/1+/NC 2+/3+/NC 1+/2+/NC -/-/-
 HPV-E4  type11(contro -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/-
             type6 * * 3+/2+/C * * * * *
             type16 * * 2+/2+/NC 2+/1+/C * 3+/2+/N 1+/1+/NC *
             type18 +/+/NC * * * 3+/1+/C * * *
             type33 * 2+/2+/C 2+/1+/N * * * * *
HPV L1 +/+/C +/+/C +/+/C 2+/1+/C -/-/- +/+/C -/-/- -/-/-
-
-
                            signal intensity; -; negative 1+; moderate, 2+; strong









Table1. Demographic data of inverted papilloma cases
-
type 6/11 probe - - -
AD
B
C
CA B
D
A B
C D
0
1
2
3
4
5
6
7
8
p16 mcm7
atypical typical
A B
C D
A B
C D
